Literature DB >> 2948111

Cross-linking of IgE-receptor complexes at the cell surface: synthesis and characterization of a long bivalent hapten that is capable of triggering mast cells and rat basophilic leukemia cells.

P Kane, J Erickson, C Fewtrell, B Baird, D Holowka.   

Abstract

The ability of a series of bivalent haptens to bind and cross-link immunoglobulin E (IgE) in solution and on the surface of cells was examined. Several short (less than 30 A) dinitrophenyl (DNP) haptens were found to bind tightly to and cross-link a monoclonal anti-DNP IgE in solution, but these failed to trigger substantial release of 3H-serotonin from sensitized rat basophilic leukemia (RBL) cells or rat peritoneal mast cells. A longer bivalent hapten, approximately 50 A in length, consisting of two DNP-aminocaproyl-L-tyrosine (DCT) groups coupled to the alpha-amino groups of L-cystine was synthesized and characterized. This bivalent hapten [(DCT)2-cystine], binds very tightly to the same monoclonal anti-DNP IgE in solution and cross-links these antibodies to form higher mol. wt aggregates as judged by gel filtration and binding studies. It also stimulates degranulation of both RBL and mast cells sensitized with two different monoclonal anti-DNP IgE antibodies, with the mast cells exhibiting generally greater responsiveness to this ligand. The (DCT)2-cystine bivalent hapten appears to have the structural features necessary for carrying out detailed binding studies with receptor-bound IgE on the cell surface.

Entities:  

Mesh:

Substances:

Year:  1986        PMID: 2948111     DOI: 10.1016/0161-5890(86)90090-8

Source DB:  PubMed          Journal:  Mol Immunol        ISSN: 0161-5890            Impact factor:   4.407


  12 in total

1.  Steric effects on multivalent ligand-receptor binding: exclusion of ligand sites by bound cell surface receptors.

Authors:  W S Hlavacek; R G Posner; A S Perelson
Journal:  Biophys J       Date:  1999-06       Impact factor: 4.033

2.  Trivalent antigens for degranulation of mast cells.

Authors:  Richard G Posner; Dianliang Geng; Seth Haymore; James Bogert; Israel Pecht; Arieh Licht; Paul B Savage
Journal:  Org Lett       Date:  2007-08-11       Impact factor: 6.005

3.  Modeling multivalent ligand-receptor interactions with steric constraints on configurations of cell-surface receptor aggregates.

Authors:  Michael I Monine; Richard G Posner; Paul B Savage; James R Faeder; William S Hlavacek
Journal:  Biophys J       Date:  2010-01-06       Impact factor: 4.033

4.  The SCHOOL of nature: I. Transmembrane signaling.

Authors:  Alexander B Sigalov
Journal:  Self Nonself       Date:  2010-01

5.  The effect of receptor density on the forward rate constant for binding of ligands to cell surface receptors.

Authors:  J Erickson; B Goldstein; D Holowka; B Baird
Journal:  Biophys J       Date:  1987-10       Impact factor: 4.033

6.  Quantifying aggregation of IgE-FcepsilonRI by multivalent antigen.

Authors:  W S Hlavacek; A S Perelson; B Sulzer; J Bold; J Paar; W Gorman; R G Posner
Journal:  Biophys J       Date:  1999-05       Impact factor: 4.033

7.  A synthetic trivalent hapten that aggregates anti-2,4-DNP IgG into bicyclic trimers.

Authors:  Basar Bilgiçer; Demetri T Moustakas; George M Whitesides
Journal:  J Am Chem Soc       Date:  2007-02-28       Impact factor: 15.419

8.  Nanoparticle-mediated IgE-receptor aggregation and signaling in RBL mast cells.

Authors:  Yu-Fen Huang; Haipeng Liu; Xiangling Xiong; Yan Chen; Weihong Tan
Journal:  J Am Chem Soc       Date:  2009-12-02       Impact factor: 15.419

9.  Dimerization kinetics of the IgE-class antibodies by divalent haptens. II. The interactions between intact IgE and haptens.

Authors:  R Schweitzer-Stenner; A Licht; I Pecht
Journal:  Biophys J       Date:  1992-08       Impact factor: 4.033

10.  Association of the crosslinked IgE receptor with the membrane skeleton is independent of the known signaling mechanisms in rat basophilic leukemia cells.

Authors:  J R Apgar
Journal:  Cell Regul       Date:  1991-03
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.